SCHEMBL31310705

SCHEMBL31310705

FC(F)(F)c1ccc(Br)c(C2CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.47
CHRNA4 P43681 2/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
PNMT P11086 1/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.41
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
HTR2C P28335 7/20 0.38
HTR2A P28223 3/20 0.38
HTR2B P41595 3/20 0.38
KDM4C Q9H3R0 1/20 0.37
KDM1A O60341 1/20 0.37
PDE2A O00408 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16311794 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL3408785 0.91 PTGDR2 (0.51) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL15269917 0.88 HTR2C (0.56) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL15010912 0.85 ALDH1A1 (0.43) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL9882913 0.85 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL15269807 0.83 PNMT (0.41) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL26795661 0.81 ALDH1A1 (0.36)
SCHEMBL15012563 0.81 RBP4 (0.46) PTGDR2MRGPRX4HTR2A
SCHEMBL11820052 0.80 CHRNB2 (0.41) CHRNB2CHRNA4CHRNB4CHRNA3PNMT
SCHEMBL17141508 0.79 IDO1 (0.44) CHRNB2CHRNA4CHRNB4CHRNA3PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119306664-A Novel heterocyclic compounds as Pol theta inhibitors for the treatment and prevention of cancer and pharmaceutical compositions containing the same 株式会社大熊制药 2025-01-14 CN disclosed